These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17222406)

  • 1. Intravenous heparin in combination with antibiotics for the treatment of deep vein septic thrombophlebitis: a systematic review.
    Falagas ME; Vardakas KZ; Athanasiou S
    Eur J Pharmacol; 2007 Feb; 557(2-3):93-8. PubMed ID: 17222406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of proximal deep venous thrombosis of the legs by low-molecular-weight heparin: a systematic review].
    Lamy O; Cornuz J; Yersin B
    Schweiz Med Wochenschr; 1999 May; 129(18):707-14. PubMed ID: 10407944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of deep vein thrombosis with low-molecular-weight heparins: a consensus statement of the Gesellschaft für Thrombose-und Hämostaseforschung (GTH).
    Harenberg J; Schmitz-Huebner U; Breddin KH; Hass S; Heinrich F; Heinrichs C; Kienast J; Roebruck P; Theiss W; Wenzel E
    Semin Thromb Hemost; 1997; 23(1):91-6. PubMed ID: 9156416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of venous thromboembolism with low-molecular-weight heparins].
    Haas S; Haas P; Creutzig A
    Vasa; 2000 Feb; 29(1):5-10. PubMed ID: 10731882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.
    Harenberg J; Stehle G; Blauth M; Huck K; Mall K; Heene DL
    Semin Thromb Hemost; 1997; 23(1):83-90. PubMed ID: 9156415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Puerperal septic pelvic thrombophlebitis: incidence and response to heparin therapy.
    Brown CE; Stettler RW; Twickler D; Cunningham FG
    Am J Obstet Gynecol; 1999 Jul; 181(1):143-8. PubMed ID: 10411810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient therapy with low-molecular-weight heparins: new perspectives for treatment of deep vein thrombosis.
    Büller HR
    Haemostasis; 1998; 28 Suppl 3():91-4. PubMed ID: 10069767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and coagulation parameters in relationship to phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis.
    Breddin HK; Kadziola Z; Scully M; Nakov R; Misselwitz F; Kakkar VV
    Thromb Haemost; 2003 Feb; 89(2):272-7. PubMed ID: 12574806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy of deep venous thrombosis].
    Mesters RM
    Internist (Berl); 1999 Oct; 40(10):1098-9. PubMed ID: 10610366
    [No Abstract]   [Full Text] [Related]  

  • 10. New perspectives for treatment of pulmonary embolism.
    Simonneau G
    Haemostasis; 1998; 28 Suppl 3():95-9. PubMed ID: 10069768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group.
    van den Belt AG; Bossuyt PM; Prins MH; Gallus AS; Büller HR
    Thromb Haemost; 1998 Feb; 79(2):259-63. PubMed ID: 9493572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 13. Septic deep vein thrombosis.
    Ang AK; Brown OW
    J Vasc Surg; 1986 Dec; 4(6):563-6. PubMed ID: 3783832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: outcome of therapy and health economy aspects.
    Hull RD; Pineo GF; Raskob GE
    Haemostasis; 1998; 28 Suppl 3():8-16. PubMed ID: 10069757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superficial thrombophlebitis of the legs: a randomized, controlled, follow-up study.
    Belcaro G; Nicolaides AN; Errichi BM; Cesarone MR; De Sanctis MT; Incandela L; Venniker R
    Angiology; 1999 Jul; 50(7):523-9. PubMed ID: 10431991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unfractionated versus low-molecular-weight heparin for deep venous thrombosis.
    Strandness DE
    N Engl J Med; 1996 Aug; 335(9):670-1; author reply 671-2. PubMed ID: 8692246
    [No Abstract]   [Full Text] [Related]  

  • 17. Unfractionated versus low-molecular-weight heparin for deep venous thrombosis.
    Penner J
    N Engl J Med; 1996 Aug; 335(9):671; author reply 671-2. PubMed ID: 8692247
    [No Abstract]   [Full Text] [Related]  

  • 18. Early versus delayed introduction of oral vitamin K antagonists in combination with low-molecular-weight heparin in the treatment of deep vein thrombosis. a randomized clinical trial. The ANTENOX Study Group.
    Leroyer C; Bressollette L; Oger E; Mansourati J; Chèze-Le Rest C; Nonent M; Buchmuller A; Tardy B; Decousus H; Parent F; Simonneau G; Juste K; Ill P; Abgrall JF; Clavier J; Mottier D
    Haemostasis; 1998; 28(2):70-7. PubMed ID: 10087431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.
    Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S
    Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which DVT patients could be considered the best candidates for home therapy?
    Monreal M
    Thromb Haemost; 1999 Jun; 81(6):996-7. PubMed ID: 10404787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.